Compare HHS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HHS | XCUR |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 26.6M |
| IPO Year | N/A | N/A |
| Metric | HHS | XCUR |
|---|---|---|
| Price | $3.19 | $6.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.1K | ★ 1.8M |
| Earning Date | 11-10-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $166,841,000.00 | N/A |
| Revenue This Year | $6.54 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.33 | $3.10 |
| 52 Week High | $5.92 | $22.99 |
| Indicator | HHS | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 58.13 |
| Support Level | $2.75 | $5.15 |
| Resistance Level | $3.23 | $6.89 |
| Average True Range (ATR) | 0.25 | 1.02 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 38.60 | 45.85 |
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.